In8Bio (INAB) Shares Outstanding (2020 - 2026)
In8Bio (INAB) recorded Shares Outstanding of 19.47 million in Q2 2026, up 372.6% from 4.12 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Shares Outstanding (2020 - 2026) Analysis & Trends
For FY2025, In8Bio reported Shares Outstanding of 4.37 million, up 145.1% from FY2024.
- Annual Shares Outstanding has increased for five straight years, with a five-year compound annual growth rate of 107.4% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding came in at 1.78 million in FY2024 (+79.3%), 995,398 in FY2023 (+42.4%), 698,862 in FY2022 (+110.3%) and 332,291 in FY2021 (+191.6%).
- Quarterly Shares Outstanding has ranged from 332,291 in Q4 2021 to 19.47 million in Q1 2026 over the past five years.
- On a year-over-year basis, Shares Outstanding has increased for 21 consecutive quarters, with growth averaging 212.6% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding ranged from 31.6% (Q1 2023) to 599.6% (Q1 2026).
- Per Business Quant, the preceding three quarters came in at 19.47 million (Q1 2026), 4.37 million (Q4 2025) and 4.54 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 892.40 Mn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 1.94 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 1.55 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 540.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 5.70 Bn |
| 10 | In8Bio | 20.25 Mn | -58.10 Mn | - | 19.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.47 Mn |
| Mar 31, 2026 | 19.47 Mn |
| Dec 31, 2025 | 4.37 Mn |
| Sep 30, 2025 | 4.54 Mn |
| Jun 30, 2025 | 4.12 Mn |
| Mar 31, 2025 | 2.78 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | 995,398.00 |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 948,983.00 |
| Mar 31, 2023 | 824,337.00 |
| Dec 31, 2022 | 698,862.00 |
| Sep 30, 2022 | 721,979.00 |
| Jun 30, 2022 | 627,560.00 |
| Mar 31, 2022 | 626,622.00 |
| Dec 31, 2021 | 332,291.00 |
| Sep 30, 2021 | 445,878.00 |
API Access
In8Bio Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();